Skip to content

Comparative study of the effect of pulsatile flow vresus non pulsatile flow on the antioxidant markers pre cardiopulmonary bypass in patients undergoing complex cardiac surgery

Comparative study of the effect of pulsatile flow vresus non-pulsatile flow on the antioxidant markers pre cardiopulmonary bypass in patients undergoing complex cardiac surgery

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20240316061314N1
Enrollment
44
Registered
2024-07-26
Start date
2024-06-21
Completion date
Unknown
Last updated
2024-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients undergoing complex cardiac surgery. Mechanical complication of coronary artery bypass graft and biological heart valve graft

Interventions

Intervention 1: Intervention group: Intervention group: Group A: 60 pulses per minute, the rest of the settings are the same and are as follows: 30% Base Flow and Pulse Width by default 40% but accord

Sponsors

Rajaee heart center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Patients conscious satisfaction Age range of 18 to 75 Patients undergoing elective complex surgery on CPB Patients with 30% = Ejection fraction Having no history of heart surgery Having no liver dysfunction AST>140 unite / L and ALT>40 unite / L and no lung dysfunction like FEV1>65% CR10 Having no active inflammation since 1 month ago Not using antioxidant and anti inflammatory drugs since 1 month ago

Exclusion criteria

Exclusion criteria: Aortic cross clamp time <20 min Pulse pressure <20 mmhg Redo surgeries Emergency surgeries

Design outcomes

Primary

MeasureTime frame
Examination of malondialdehyde at specified times. Timepoint: Preoperatively, immediately after bypass, 24 hours later in the intensive care unit. Method of measurement: Blood test.;Total antioxidant capacity. Timepoint: Preoperatively, immediately after bypass, 24 hours later in the intensive care unit. Method of measurement: Blood test.;Lactat. Timepoint: Preoperatively, immediately after bypass, 24 hours later in the intensive care unit. Method of measurement: Blood test.

Secondary

MeasureTime frame
ICU stay. Timepoint: Post operative. Method of measurement: patients file.;Ventilation time. Timepoint: Post operative. Method of measurement: Patients file.;Reducing mortality and morbidity. Timepoint: Post operative. Method of measurement: patients file.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactArezoo Moradi

Rajaee heart center

arezoo.m07@gmail.com+98 21 23921

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026